These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5374413)

  • 21. [Statin treatment in type 2 diabetes. Is it a must today?].
    Faust M
    MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of dyslipidemias and its benefits].
    Taskinen MR
    Duodecim; 1999; 115(10):1138-44. PubMed ID: 11877853
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of potassium orotate in patients with diabetes mellitus].
    Lesnichiĭ AV
    Klin Med (Mosk); 1970 May; 48(5):132-4. PubMed ID: 5434060
    [No Abstract]   [Full Text] [Related]  

  • 24. The medical treatment of atherosclerosis.
    Nye ER
    N Z Med J; 1967 Jul; 66(419):460-4. PubMed ID: 4861361
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of diet therapy including eiconol on clinical and metabolic parameters in patients with type 2 diabetes mellitus].
    Alekseeva RI; Sharafetdinov KhKh; Plotnikova OA; Meshcheriakova VA; Mal'tsev GIu; Kulakova SN
    Vopr Pitan; 2000; 69(5):36-9. PubMed ID: 11247166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical experience with an antilipemic agent, ethylchlorophenoxyisobutyrate].
    Noleto PA; de Bulhões F; Tuma M
    Rev Bras Med; 1969 Oct; 26(10):602-5. PubMed ID: 5404870
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study of the antilipemic effect of etofibrate (Lipo-Merz)].
    Słowińska R; Bochenek W; Unlot J
    Pol Tyg Lek; 1983 Apr; 38(17):529-32. PubMed ID: 6356087
    [No Abstract]   [Full Text] [Related]  

  • 28. [Indices of lipid metabolism in patients with diabetes mellitus associated with atherosclerosis].
    Shifrin MA
    Vrach Delo; 1965 Dec; 12():58-61. PubMed ID: 5873728
    [No Abstract]   [Full Text] [Related]  

  • 29. [Current views on the liver-protective therapy: clinical evaluation of 4-amino-5-carbamide imidazole 2,4-dihydroxy-6-pyrimidine carbonate].
    Tàmmaro AE; Bonaccorso O
    Clin Ter; 1975 Oct; 75(2):141-51. PubMed ID: 1227763
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of cetamiphen on coagulative properties of blood in patients with coronary arteriosclerosis].
    Zelenskaia LM
    Vrach Delo; 1975 Jul; (7):68-70. PubMed ID: 1220236
    [No Abstract]   [Full Text] [Related]  

  • 31. Basic aspects and clinical applicability in the field of lipidology. Foreword.
    LeRoith D
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):xiii-xv. PubMed ID: 19217508
    [No Abstract]   [Full Text] [Related]  

  • 32. [AVERT study (Atorvastatin Versus Revascularization Treatment). Clinical advantage of aggressive lipid lowering].
    Z Kardiol; 1999 Mar; 88(3 Suppl):1-4. PubMed ID: 10330699
    [No Abstract]   [Full Text] [Related]  

  • 33. [Inclusion of products enriched with vitamins B complex into ration for elderly with diabetes mellitus].
    Ryzhkova KG; Fedishin PS; Sinitsina FF
    Vrach Delo; 1977 Sep; (9):110-13. PubMed ID: 919462
    [No Abstract]   [Full Text] [Related]  

  • 34. Lipid lowering and recurrent stroke: another stroke paradox?
    Amarenco P
    Eur Heart J; 2005 Sep; 26(18):1818-9. PubMed ID: 16087646
    [No Abstract]   [Full Text] [Related]  

  • 35. Utility of currently available modes of therapy in reaching lipid goals.
    Spratt KA; Denke MA
    J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S14-6. PubMed ID: 15467019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The use of Stresscaps in diabetics].
    Shi-Hsien Tsai
    Hospital (Rio J); 1967 Jan; 71(1):145-50. PubMed ID: 4234102
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dyslipidemias and diabetes mellitus].
    Pometta D
    Journ Annu Diabetol Hotel Dieu; 1989; ():47-54. PubMed ID: 2668624
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid-lowering agents.
    Chase S
    RN; 1997 Sep; 60(9):47-51; quiz 52. PubMed ID: 9348987
    [No Abstract]   [Full Text] [Related]  

  • 39. Expert commentary: gastrointestinally active lipid-lowering drug safety.
    Toth PP
    Am J Cardiol; 2007 Mar; 99(6A):56C-58C. PubMed ID: 17368280
    [No Abstract]   [Full Text] [Related]  

  • 40. [How sure is the combined lipid lowering?].
    Schäfer J
    MMW Fortschr Med; 2005 Jan; 147(1-2):56. PubMed ID: 15704576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.